Everything below concerns purity. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-26. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (with DAC) | ~3647 Da | Calculated from the full amino acid sequence |
| Molecular weight (without DAC) | ~3368 Da | Mod GRF(1-29) variant |
| Appearance | White lyophilized powder | Typical form supplied for research |
| Solubility | Soluble in water | Dissolves in aqueous buffers |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
== Causes == Childhood obesity can be brought on by a range of factors which often act in combination. "Obesogenic environment" refers to a mixture of environmental factors that are permissive of obesity, especially for those who are genetically predisposed. The greatest risk factor for child obesity is the obesity of both parents. This may be reflected by the family's environment and genetics. Other reasons may also be due to psychological factors and the child's body type. A 2010 review stated that childhood obesity likely is the result of the interaction of natural selection favouring those with more parsimonious energy metabolism and today's consumerist society with easy access to cheap, energy-dense foods and less energy requirements in daily life. Factors include the increase in use of technology, increase in snacks and portion size of meals, and the decrease in the physical activity of children. A study found that children who use electronic devices three or more hours a day had between a 17–44% increased risk of being overweight, or a 10–61% increased risk of obesity (Cespedes 2011). Childhood obesity is common among children from low-income, African American and Hispanic communities. This is mainly because minority children spend less time playing outside the house and staying active. Parents may prefer their children stay inside the home because they fear gang and drug violence and other dangers.
=== Treatment of corneal thinning === Keratoconus is the most common form of corneal ectasia, a progressive thinning of the cornea. The condition is treated by corneal collagen cross-linking, which increases corneal stiffness. Cross-linking is achieved by applying a topical riboflavin solution to the cornea, which is then exposed to ultraviolet A light.
This should in no way suggest to clinicians or researchers that inhaled particles are not a greater threat than swallowed particles, it merely signifies that a combination of both methods may occur with some particles, no matter the size of or lipo/hydrophilicity of the different particle surfaces.
Sources: en.wikipedia.org
== External links == "Pivekimab Sunirine ( Code - C184834 )". EVS Explore. Clinical trial number NCT03386513 for "Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN" at ClinicalTrials.gov
Paul Hellquist, the game's lead designer, was often omitted from key design meetings, which he considered due to questioning Levine's choices; he redirected his frustration into improving the Medical Pavilion level that he was in charge of at that time. Near the anticipated completion date, 2K Games decided to give Irrational another three months to polish up the game, extending the crunch time the studio was already under. After early rounds of positive feedback from family and friends, 2K used a beta version to conduct wider focus tests of the first level. Initial feedback from players was negative; players were lost and confused by the level, did not know how to use newly-acquired powers, and missed key story information. Testers distrusted the Atlas character, who at the time was voiced in a southern accent one tester described as a "lecherous Colonel Sanders". Project lead Alyssa Finley called the feedback "brutal", but humbling: the team realized that they were making a complex game that was not accessible to a variety of players. The opening levels of the game were redesigned to be more deliberate experiences that taught players key mechanics. The lighting was adjusted, a quest marker added for player way finding, and Atlas was given an Irish accent to make him sound more trustworthy.
It also saw the first "Era of Progress" as the college transformed from a college supported by the religious community (which focused primarily upon training young men and women for the ministry) to a college gaining support from private foundations, and offering liberal arts academic degree for a variety of professions. In 1915, Andrew Carnegie donated to the school a grant of $50,000 for a central academic building. The terms of the grant included the purchase of a new site for the College, payment of all outstanding obligations, and the construction of a building to be named after him. The College met the conditions and moved to its present site in northeast Baltimore in 1917. In 1918, the white community of Lauraville tried to have the sale revoked by filing suit in the circuit court in Towson, upset that the Ivy Mill property, the planned location of Morgan State, had been sold to a "negro" college. The circuit court dismissed the suit, which the community appealed to the Maryland Court of Appeals. The appellate court upheld the lower court decision, finding no basis that siting the college at this location would constitute a public nuisance. Despite some ugly threats and several demonstrations against the project, Morgan College was constructed at the new site and later expanded. Carnegie Hall, the oldest original building on the present Morgan campus, was erected a year later. Morgan remained a private institution until 1939. That year, the state of Maryland purchased the school. Morgan College became Morgan State College.
Sources: en.wikipedia.org
Comb jellies, members of Ctenophora, are radially symmetric and have digestive chambers with a single opening, which serves as both mouth and anus. Ctenophora have distinct tissues, but these are not organised into discrete organs. They move using large arrays of cilia, called swimming plates. Almost all comb jellies are predatory. They have are unique in having colloblasts, structures on their tentacles that help them catch prey. They have nerve cells, but lack a brain or central nervous system. Instead their nerves are arranged into a nerve net. Their nerves are very different from those of other animals, and evidence suggests that their nerves developed independently of the nerves of other animals.
== Personal life == Culp was married five times: to Elayne Carroll (1951–1956), Nancy Ashe (1957–1966), French actress France Nuyen, whom he met when she guest-starred on I Spy (1967–1970), Sheila Sullivan (1971–1976), and Candace Faulkner (from 1981). In addition to appearing in four episodes of I Spy, two of them written by Culp, in 1969 Nuyen also co-hosted the second episode of the TV comedy Turn-On with him, but the program was never shown, as the series was cancelled after its first airing. Culp had three sons and a daughter with his second wife, and a daughter with his fifth wife. That daughter, producer Samantha Culp, married author Matthew Specktor in 2021.His son Joseph Culp is an actor and director; his son Jason Culp is a voice actor who has narrated many audiobooks. Culp's grandson, Elmo Kennedy O'Connor, is a rapper and performs under the alias Bones. Culp's appearances on The Outer Limits led to a longtime friendship with Harlan Ellison who wrote for the series.
Nearly a decade after the war, the Romans set up colonies at Tempsa and Kroton (Croto in Latin) in 194 BCE, Copiae in the territory of Thurii (Thurium in Latin) in 193 BCE, and Vibo Valentia in the territory of Hipponion in 192 BCE. Starting in the third century BCE, the name Calabria was given to the Adriatic coast of the Salento peninsula in modern Apulia. In the first century BCE this name extended to the entirety of the Salento, when the Roman emperor Augustus divided Italy into regions and modern Calabria was known as Regio III Lucania et Bruttii. From 186 BCE, repression of the Bacchanalia, and of the Greek cult of Bacchus, is triggered throughout Magna Graecia as part of a plan to Romanize southern Italy. Between 136 and 132 BCE, the First Servile War was fought in Sicily. The Syrian slave Eunus gathered some 200,000 serfs, proclaiming himself king, and for four years held out against the Roman legions from Enna and Taormina. Eventually Rome crushed the repression and crucified 20,000 slaves throughout the island. The Servile war was an expression of the slave class' discontent, on whom the entire Roman economy rested. In 132 BCE the consul Popilius Lenate ordered the construction of the Via Capua-Rhegium, also known as Via Popilia, which, tracing the route now occupied by A2 Highway and State Road 18 Tirrena, reached Reggio. In this period the main towns were Cosenza, Crotone, Temesa, Turi, Vibo Valentia Taurianum, and Reggio. Between 91 and 89 BCE the Social War was fought, at the end of which the Roman Senate granted the Italics Roman citizenship.
== Key people == The Santa Monica-based startup was founded in September 2011 by Trevor Bezdek and former Facebook executives Doug Hirsch and Scott Marlette. Marlette was one of the first 20 employees at Facebook and built Facebook's photo application. In 2005, Hirsch was the Vice President of Product at Facebook, working closely with Mark Zuckerberg. Bezdek and Hirsch served as co-chief executive officers until April 2023, when they stepped down from those roles and technology executive Scott Wagner was appointed interim chief executive officer. Bezdek became chair of the board, while Hirsch took on the role of chief mission officer. In December 2024, GoodRx announced that healthcare executive Wendy Barnes would become president and chief executive officer effective January 1, 2025. As of 2025, Barnes serves as the company's CEO, while Trevor Bezdek and Scott Wagner serve as co-chairs of the board, and Doug Hirsch remains involved as a co-founder and senior executive.
Sources: en.wikipedia.org
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.
The maleimide group forms a covalent link with albumin, an abundant blood protein. This attachment slows clearance, so a single administration persists much longer than the unmodified peptide. The feature is the main reason the two variants are handled differently in study design.
It is not an approved therapeutic product in major regulatory jurisdictions. It appears in research chemical catalogs and scientific literature rather than pharmacy shelves. Clinical development was limited and did not reach approval.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.